
Patent Law Weblog
recent posts
- In re Magnolia Medical Technologies, Inc. (Fed. Cir. 2026)
- Improving the Abstract Idea: How a Rhetorical Move Undermines § 101 Analysis of Technical Improvements in Software Inventions
- Melinta Therapeutics, LLC v. Nexus Pharmaceuticals, Inc. (Fed. Cir. 2026)
- The State of Software Patent Eligibility in 2026
- USPTO Revises Conditions for Requiring Additional Information in Petitions Based on Unintentional Delay

Leave a comment